Freedom of Information request on RMP -RobinulR 200 micrograms/ml Solution for Injection (FOI 22/573 )
Published 1 June 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-31-march-2022/freedom-of-information-request-on-rmp-robinulr-200-microgramsml-solution-for-injection-foi-22573
FOI 22/573
31st March 2022
FOI request: RMP -RobinulR 200 micrograms/ml Solution for Injection
Dear
Thank you for getting in contact. The license for PLPI 20636/2899 has been cancelled, and so we are unable to provide an RMP.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Division
Medicines and Healthcare Products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU